Immunogenomics-guided adaptive cellular therapies in Multiple Myeloma

Basic Information

Funding Cycle : 2021-2022
Name : Paola Neri
Type of Award : Translational Research Award
Home Institution : University of Calgary, Cumming School of Medicine, Calgary, Canada


This proposal aimed to interrogate at single cell level the tumor microenvironment of CAR-T and TCE treated MM patients to elucidate the immune-mediated causes of resistance, identify potential means to reverse tolerance, and study how genomics might predict which patients should benefit the most from T-cell based therapies.

Why Become a Member

The International Myeloma Society is a professional, scientific, and medical society established to bring together clinical and experimental scientists involved in the study of myeloma. The purpose of this society is to promote research, education, clinical studies (including diagnosis and treatment), workshops, conferences, and symposia on all aspects of multiple myeloma worldwide.

The IMS is a membership organization comprised of basic research scientists, and clinical investigators in the field along with physicians and other healthcare practitioners.

Stay updated on our Events